Thermo Fisher Scientific Inc. TMO

NYSE · Healthcare · Medical - Diagnostics & Research

$669.54

Close on Fri, 20 Nov 2026 · market value $248B

What the price is betting on

Priced for a lot to go right

At $670, the price assumes revenue grows about 13% a year for five years, from $47.4B to about $80.5B by FY2030. That is about twice what analysts expect for the next two years and about four times the company's own last three years.

The price assumes13%
Analysts, next two years5.7%
Last 3 years3.7%

Revenue growth a year. The price figure comes from a reverse DCF at a 8.5% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than TMO? Check up to 5 of your stocks at once, free, no account.

0$25B$50B$75B$100B$47.4B'22'23'24'25Sep '26'26'27'28'29'30What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$394

Base

$450

Bull

$512

Today $670

  • Bear $394. Cash flow grows 4% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $450. Cash flow grows 6% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $512. Cash flow grows 8% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$48.9B$48B, on the path
  3. FY2027$55.4B$50.6B, below the path
  4. FY2028$62.8B$53.8B, below the path
  5. FY2029$71.1B$57.2B, below the path
  6. FY2030$80.5B$59.2B, below the path

Each year's revenue at 13% growth from $47.4B in the 12 months to September 2026.

At a glance

Healthcare · Medical - Diagnostics & Research · listed on NYSE

Revenue, FY2025
$44.6B
Growth, 3 years a year
3.7%
Cash margin
14%
Net debt
$29.3B
Shares, 3-year change
−4.3%
Dividend yield
0.3%

What other healthcare prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.